PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation
Chao Hu(Zhejiang University), Hongyan Tong(First Affiliated Hospital Zhejiang University)
Cited by 22
Related Papers
Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target
|Journal of Translational Medicine|2014|48
RIPK3 deficiency blocks R-2-hydroxyglutarate–induced necroptosis in IDH-mutated AML cells
|Science Advances|2024|19
miR-550-1 functions as a tumor suppressor in acute myeloid leukemia via the hippo signaling pathway
|International Journal of Biological Sciences|2020|18